Mergers and Inquisitions

DECEMBER 4, 2024

No matter the economic climate, you can always bet on sports fans to show up for their favorite teams. This sector is the most different in terms of valuation and technical analysis because of nuances around licensing, player salaries, and different revenue streams.

Investment Banking 106

Investment Banking Bank Banking Investment 106

CNBC: Investing

JUNE 21, 2025

Meanwhile, brokerage stocks Raymond James and LPL Financial could offer discounts since both names are trading at a cheaper valuation than the overall index, but providing investors with materially stronger revenue growth and earnings, he said.

Investors 113

Investors Stock S&P Investment 113

Software Equity Group

MARCH 26, 2024

And it typically boils down to a few common elements that successful SaaS companies do particularly well: High-quality SaaS companies feature predictable, recurring revenues, solid unit economics , and high gross margin and gross profit rates. The firm currently employs 31 professionals. The firm employs 93 professionals.

Private Equity 52

Private Equity Equities Investment Valuation 52

Sun Acquisitions

JULY 1, 2024

Sellers must carefully assess market conditions, industry trends, and economic landscape. By understanding market cycles and potential buyer behavior, sellers can strategically time their business transition to coincide with peak interest and valuation, ultimately maximizing returns.

Business 59

Business Negotiation Mergers and Acquisitions M&A 59

Devensoft

JUNE 20, 2023

Valuation methods can include discounted cash flow analysis, comparable company analysis, and precedent transaction analysis. Due Diligence Guide for Today’s M&A Navigate M&A due diligence in a turbulent economic landscape with confidence.

M&A 52

M&A Corporation Mergers and Acquisitions Mergers 52

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

FEBRUARY 1, 2024

Private equity slowed but not stopped by financing environment Despite record amounts of dry powder accumulating for sponsors, high financing costs, persistent valuation gaps and a closed tech IPO market led to a significant decrease in private equity M&A activity in 2023.

M&A 59

M&A Mergers and Acquisitions Private Equity Equities 59